ERAP2 and familial pancreatic carcinoma: Overall, these findings demonstrate that ER stress and the resulting UPR signaling pathway trigger ERAP2-dependent autophagy and PSC activation, uncovering the benefits of targeting ERAP2 as a potentially promising strategy for the treatment of pancreatic cancer (Guan et al., 2022).